argenx Management
Management criteria checks 2/4
argenx's CEO is Tim Van Hauwermeiren, appointed in Apr 2008, has a tenure of 16.67 years. total yearly compensation is $11.94M, comprised of 5.5% salary and 94.5% bonuses, including company stock and options. directly owns 0.023% of the company’s shares, worth R$53.53M. The average tenure of the management team and the board of directors is 2.8 years and 7.7 years respectively.
Key information
Tim Van Hauwermeiren
Chief executive officer
US$11.9m
Total compensation
CEO salary percentage | 5.5% |
CEO tenure | 16.7yrs |
CEO ownership | 0.02% |
Management average tenure | 2.8yrs |
Board average tenure | 7.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$40m |
Jun 30 2024 | n/a | n/a | -US$204m |
Mar 31 2024 | n/a | n/a | -US$328m |
Dec 31 2023 | US$12m | US$656k | -US$295m |
Sep 30 2023 | n/a | n/a | -US$234m |
Jun 30 2023 | n/a | n/a | -US$397m |
Mar 31 2023 | n/a | n/a | -US$511m |
Dec 31 2022 | US$8m | US$639k | -US$710m |
Sep 30 2022 | n/a | n/a | -US$909m |
Jun 30 2022 | n/a | n/a | -US$907m |
Mar 31 2022 | n/a | n/a | -US$595m |
Dec 31 2021 | US$7m | US$652k | -US$408m |
Sep 30 2021 | n/a | n/a | -US$373m |
Jun 30 2021 | n/a | n/a | -US$319m |
Mar 31 2021 | n/a | n/a | -US$573m |
Dec 31 2020 | US$9m | US$641k | -US$608m |
Sep 30 2020 | n/a | n/a | -US$535m |
Jun 30 2020 | n/a | n/a | -US$359m |
Mar 31 2020 | n/a | n/a | -US$275m |
Dec 31 2019 | US$7m | US$589k | -US$181m |
Sep 30 2019 | n/a | n/a | -US$109m |
Jun 30 2019 | n/a | n/a | -US$104m |
Mar 31 2019 | n/a | n/a | -US$47m |
Dec 31 2018 | US$5m | US$573k | -US$76m |
Sep 30 2018 | n/a | n/a | -US$56m |
Jun 30 2018 | n/a | n/a | -US$47m |
Mar 31 2018 | n/a | n/a | -US$46m |
Dec 31 2017 | US$4m | US$365k | -US$34m |
Compensation vs Market: Tim's total compensation ($USD11.94M) is above average for companies of similar size in the BR market ($USD5.74M).
Compensation vs Earnings: Tim's compensation has increased whilst the company is unprofitable.
CEO
Tim Van Hauwermeiren (52 yo)
16.7yrs
Tenure
US$11,944,835
Compensation
Mr. Timothy Van Hauwermeiren, also known as Tim, MSc, EMBA, serves as Independent Non-Executive Director of Lexeo Therapeutics, Inc since July 2024. He has been Independent Director at iTeos Therapeutics,...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Executive Director | 16.7yrs | US$11.94m | 0.023% R$ 53.5m | |
Chief Financial Officer | 3.5yrs | US$4.76m | 0.0049% R$ 11.4m | |
Chief Operating Officer | 1.8yrs | US$7.65m | no data | |
VP & Global Head of Technical Operations | 2.7yrs | no data | no data | |
Chief Scientific Officer | 1.9yrs | no data | 0.00085% R$ 2.0m | |
VP and Global Head of Corporate Communications & Investor Relations | 2.7yrs | no data | no data | |
General Counsel | 2.8yrs | no data | 0% R$ 0 | |
Vice President of Corporate Development & Strategy | 5.5yrs | no data | 0.0020% R$ 4.7m | |
Global Head of Human Resources | 6yrs | no data | no data | |
Global Head of Quality | 4.9yrs | no data | 0.00050% R$ 1.2m | |
Chief Medical Officer | 2.7yrs | no data | 0.0027% R$ 6.3m |
2.8yrs
Average Tenure
52yo
Average Age
Experienced Management: A1RG34's management team is considered experienced (2.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Executive Director | 10.4yrs | US$11.94m | 0.023% R$ 53.5m | |
Independent Vice-Chairman of the Board | 9.6yrs | US$482.23k | 0.00064% R$ 1.5m | |
Independent Chairman of the Board | 10.4yrs | US$660.33k | 0.0023% R$ 5.3m | |
Independent Non-Executive Director | 7.7yrs | US$476.82k | 0.00064% R$ 1.5m | |
Independent Non-Executive Director | 6.6yrs | US$482.23k | 0.00064% R$ 1.5m | |
Independent Non-Executive Director | 8.7yrs | US$471.41k | 0.00064% R$ 1.5m | |
Member of Board Advisors | no data | no data | no data | |
Member of Board Advisors | no data | US$622.58k | no data | |
Independent Non-Executive Director | 1.8yrs | US$635.65k | 0.00022% R$ 509.8k | |
Independent Non-Executive Director | 2.3yrs | US$365.24k | 0.00085% R$ 2.0m | |
Member of Board Advisors | 1.8yrs | US$656.08k | 0.0055% R$ 12.7m | |
Member of Board Advisors | no data | no data | no data |
7.7yrs
Average Tenure
63.5yo
Average Age
Experienced Board: A1RG34's board of directors are considered experienced (7.7 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 04:53 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
argenx SE is covered by 49 analysts. 28 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Joel Beatty | Baird |
Charles Pitman-King | Barclays |
Richard Parkes | BNP Paribas Exane |